{"id":"NCT00317239","sponsor":"American Regent, Inc.","briefTitle":"VIT45 Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease","officialTitle":"Comparison of Safety & Efficacy of a Unique Intravenous Iron (VIT45) Preparation vs Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-05","primaryCompletion":"2007-02","completion":"2007-08","firstPosted":"2006-04-24","resultsPosted":"2013-11-25","lastUpdate":"2018-02-20"},"enrollment":255,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Anemia"],"interventions":[{"type":"DRUG","name":"Ferrous Sulfate tablets","otherNames":[]},{"type":"DRUG","name":"Ferric Carboxymaltose (FCM)","otherNames":[]}],"arms":[{"label":"Ferric Carboxymaltose (FCM)","type":"EXPERIMENTAL"},{"label":"Ferrous Sulfate tablets","type":"ACTIVE_COMPARATOR"}],"summary":"This study compares the efficacy and safety of intravenous (IV) iron (VIT45) versus oral iron (ferrous sulfate) administered to subjects who suffer from anemia and are diagnosed with non-dialysis dependent chronic kidney disease (NDD-CKD).","primaryOutcome":{"measure":"Number of Subjects Achieving an Increase in Hemoglobin â‰¥1g/dL","timeFrame":"anytime during the study","effectByArm":[{"arm":"Ferric Carboxymaltose (FCM)","deltaMin":87,"sd":null},{"arm":"Ferrous Sulfate Tablets","deltaMin":35,"sd":null}],"pValues":[]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":10},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["20929915"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":13,"n":147},"commonTop":["Constipation","Odema peripheral"]}}